CN101177688B - 突变青霉素g酰化酶、其重组表达质粒及转化的工程菌株 - Google Patents
突变青霉素g酰化酶、其重组表达质粒及转化的工程菌株 Download PDFInfo
- Publication number
- CN101177688B CN101177688B CN2006101180420A CN200610118042A CN101177688B CN 101177688 B CN101177688 B CN 101177688B CN 2006101180420 A CN2006101180420 A CN 2006101180420A CN 200610118042 A CN200610118042 A CN 200610118042A CN 101177688 B CN101177688 B CN 101177688B
- Authority
- CN
- China
- Prior art keywords
- lys
- glu
- gly
- asn
- ser
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010073038 Penicillin Amidase Proteins 0.000 title claims abstract description 38
- 230000035772 mutation Effects 0.000 title claims description 11
- 230000009466 transformation Effects 0.000 title description 5
- 239000013613 expression plasmid Substances 0.000 title description 4
- 238000003259 recombinant expression Methods 0.000 title description 4
- 108090000790 Enzymes Proteins 0.000 claims abstract description 74
- 102000004190 Enzymes Human genes 0.000 claims abstract description 73
- 239000013612 plasmid Substances 0.000 claims abstract description 51
- 241000894006 Bacteria Species 0.000 claims abstract description 35
- 241000194107 Bacillus megaterium Species 0.000 claims abstract description 27
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 23
- 244000063299 Bacillus subtilis Species 0.000 claims abstract description 8
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 140
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 138
- 238000002703 mutagenesis Methods 0.000 claims description 17
- 231100000350 mutagenesis Toxicity 0.000 claims description 17
- 230000000869 mutational effect Effects 0.000 claims description 15
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 14
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 12
- 238000000855 fermentation Methods 0.000 claims description 11
- 230000004151 fermentation Effects 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 239000004475 Arginine Substances 0.000 claims description 9
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 9
- 235000018102 proteins Nutrition 0.000 claims description 8
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims description 7
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- 239000003471 mutagenic agent Substances 0.000 claims 6
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 238000006243 chemical reaction Methods 0.000 abstract description 48
- 238000000034 method Methods 0.000 abstract description 34
- NVIAYEIXYQCDAN-CLZZGJSISA-N 7beta-aminodeacetoxycephalosporanic acid Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](N)[C@@H]12 NVIAYEIXYQCDAN-CLZZGJSISA-N 0.000 abstract description 23
- 238000003786 synthesis reaction Methods 0.000 abstract description 20
- 230000015572 biosynthetic process Effects 0.000 abstract description 19
- 239000000047 product Substances 0.000 abstract description 18
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 abstract description 8
- 239000000413 hydrolysate Substances 0.000 abstract description 5
- 238000005520 cutting process Methods 0.000 abstract description 3
- 238000002741 site-directed mutagenesis Methods 0.000 abstract 2
- 235000014469 Bacillus subtilis Nutrition 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 147
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 27
- 102220369447 c.1352G>A Human genes 0.000 description 21
- 230000008859 change Effects 0.000 description 20
- 239000007788 liquid Substances 0.000 description 16
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 14
- 229940047526 cephalexin monohydrate Drugs 0.000 description 14
- YGZIWEZFFBPCLN-UHFFFAOYSA-N n,3-bis(2-chloroethyl)-4-hydroperoxy-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine Chemical compound OOC1CCOP(=O)(NCCCl)N1CCCl YGZIWEZFFBPCLN-UHFFFAOYSA-N 0.000 description 14
- 108020004414 DNA Proteins 0.000 description 13
- 229940056360 penicillin g Drugs 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 102220023257 rs387907546 Human genes 0.000 description 12
- 239000000758 substrate Substances 0.000 description 10
- QHVQEQRGDKOHHC-UHFFFAOYSA-N 2-nitro-5-[(2-phenylacetyl)amino]benzoic acid Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(NC(=O)CC=2C=CC=CC=2)=C1 QHVQEQRGDKOHHC-UHFFFAOYSA-N 0.000 description 9
- 102220369445 c.668T>C Human genes 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000005070 sampling Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 241000588724 Escherichia coli Species 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 102220023256 rs387907547 Human genes 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000002132 β-lactam antibiotic Substances 0.000 description 6
- 229940124586 β-lactam antibiotics Drugs 0.000 description 6
- NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 description 5
- 102000003960 Ligases Human genes 0.000 description 5
- 108090000364 Ligases Proteins 0.000 description 5
- 101150016593 PGA gene Proteins 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 238000000246 agarose gel electrophoresis Methods 0.000 description 3
- 102220369446 c.1274G>A Human genes 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 102220004457 rs11567847 Human genes 0.000 description 3
- 102220023258 rs387907548 Human genes 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 2
- 241000588777 Providencia rettgeri Species 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000013016 damping Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000024188 Andala Species 0.000 description 1
- 101100016388 Arabidopsis thaliana PAS2 gene Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 101100297150 Komagataella pastoris PEX3 gene Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 1
- 101100315760 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PEX4 gene Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000005411 Van der Waals force Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- CSGFFYNMTALICU-ZWNOBZJWSA-N adipyl-7-aminodesacetoxycephalosporanic acid Natural products CC1=C(N2[C@H](SC1)[C@H](NC(=O)CCCCC(O)=O)C2=O)C(O)=O CSGFFYNMTALICU-ZWNOBZJWSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 125000003460 beta-lactamyl group Chemical group 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000000833 heterodimer Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000001261 hydroxy acids Chemical group 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000002910 structure generation Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 150000003952 β-lactams Chemical class 0.000 description 1
Images
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101180420A CN101177688B (zh) | 2006-11-08 | 2006-11-08 | 突变青霉素g酰化酶、其重组表达质粒及转化的工程菌株 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2006101180420A CN101177688B (zh) | 2006-11-08 | 2006-11-08 | 突变青霉素g酰化酶、其重组表达质粒及转化的工程菌株 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101177688A CN101177688A (zh) | 2008-05-14 |
CN101177688B true CN101177688B (zh) | 2010-12-01 |
Family
ID=39404114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006101180420A Active CN101177688B (zh) | 2006-11-08 | 2006-11-08 | 突变青霉素g酰化酶、其重组表达质粒及转化的工程菌株 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101177688B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2367940B1 (en) | 2008-12-23 | 2017-11-22 | DSM Sinochem Pharmaceuticals Netherlands B.V. | Mutant penicillin G acylases |
CN103074320B (zh) * | 2012-05-25 | 2018-06-08 | 石药集团中奇制药技术(石家庄)有限公司 | 含有一个或几个点突变的青霉素g酰化酶 |
CN103695405B (zh) * | 2013-11-11 | 2015-08-05 | 华北制药河北华民药业有限责任公司 | 一种新型β-内酰胺类抗生素合成酶的生产方法 |
CN103834631B (zh) * | 2014-02-20 | 2015-12-30 | 浙江普洛得邦制药有限公司 | 一种青霉素g酰化酶突变体及其编码基因和应用 |
CN104120120B (zh) * | 2014-06-27 | 2016-08-17 | 浙江工业大学 | 固定化重组青霉素g酰化酶及其应用 |
CN107099523B (zh) * | 2017-06-15 | 2019-09-27 | 清华大学 | 头孢拉定合成酶突变体及其编码基因 |
CN109161540B (zh) * | 2018-09-28 | 2021-03-19 | 湖南福来格生物技术有限公司 | 一种青霉素v酰化酶突变体、编码序列、重组表达载体、基因工程菌及应用 |
CN110129305B (zh) * | 2019-05-28 | 2022-10-28 | 河北凯恩利生物技术有限公司 | 一种用于制备7-aca的头孢菌素c酰化酶突变体 |
CN110343734B (zh) * | 2019-06-14 | 2021-03-23 | 浙江工业大学 | 一种l-草铵膦化学酶法生产方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891703A (en) * | 1994-08-12 | 1999-04-06 | Gist-Hrocades | Mutated penicillin G acylase genes |
US6403356B1 (en) * | 1996-11-05 | 2002-06-11 | Bristol-Myers Squibb Co. | Mutant penicillin G acylases |
WO2003055998A2 (en) * | 2001-12-27 | 2003-07-10 | Dsm Ip Assets B.V. | Process for the preparation of a beta-lactam antibiotic with mutated penicillin acylase |
-
2006
- 2006-11-08 CN CN2006101180420A patent/CN101177688B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891703A (en) * | 1994-08-12 | 1999-04-06 | Gist-Hrocades | Mutated penicillin G acylase genes |
US6403356B1 (en) * | 1996-11-05 | 2002-06-11 | Bristol-Myers Squibb Co. | Mutant penicillin G acylases |
WO2003055998A2 (en) * | 2001-12-27 | 2003-07-10 | Dsm Ip Assets B.V. | Process for the preparation of a beta-lactam antibiotic with mutated penicillin acylase |
Non-Patent Citations (8)
Title |
---|
周丽萍 等.巨大芽孢杆菌青霉素G酰化酶的定点突变及其动力学性质研究.工业微生物33 01.2003,33(01),9-13. |
周丽萍等.巨大芽孢杆菌青霉素G酰化酶的定点突变及其动力学性质研究.工业微生物33 01.2003,33(01),9-13. * |
戴明华 等.青霉素酰化酶活性中心的定点突变.生物化学与生物物理学报31 05.1999,31(05),558-562. |
戴明华等.青霉素酰化酶活性中心的定点突变.生物化学与生物物理学报31 05.1999,31(05),558-562. * |
杨晟 等.定点突变提高青霉素G酰化酶的稳定性.生物化学与生物物理学报32 06.2000,32(06),581-585. |
杨晟等.定点突变提高青霉素G酰化酶的稳定性.生物化学与生物物理学报32 06.2000,32(06),581-585. * |
陈建波 等.青霉素酰化酶及其突变体的 pH依赖性催化反应.生物化学与生物物理学报34 06.2002,34(06),786-789. |
陈建波等.青霉素酰化酶及其突变体的 pH依赖性催化反应.生物化学与生物物理学报34 06.2002,34(06),786-789. * |
Also Published As
Publication number | Publication date |
---|---|
CN101177688A (zh) | 2008-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101177688B (zh) | 突变青霉素g酰化酶、其重组表达质粒及转化的工程菌株 | |
US20130316425A1 (en) | Production of Alkenes by Combined Enzymatic Conversion of 3-Hydroxyalkanoic Acids | |
CN105483105B (zh) | 一种青霉素g酰化酶突变体 | |
Rozkov et al. | Analysis and control of proteolysis of recombinant proteins in Escherichia coli | |
CN108795916A (zh) | 一种赖氨酸脱羧酶突变体、其编码基因及其表达和应用 | |
CN104152498A (zh) | 一种酶法生产α-酮戊二酸的方法 | |
JP2011139667A (ja) | プロリンおよびβ−アラニンをN末端に有するジペプチド、及びその環化ジペプチドの酵素合成法 | |
Wu et al. | Biosynthesis of poly (γ-glutamic acid) in Bacillus subtilis NX-2: regulation of stereochemical composition of poly (γ-glutamic acid) | |
CN104131041A (zh) | 一种α-酮戊二酸的生产方法 | |
Yang et al. | Semi-quantitative activity assays for high-throughput screening of higher activity gamma glutamyl transferase and enzyme immobilization to efficiently synthesize L-theanine | |
CN111485008A (zh) | 顺式-5-羟基-l-六氢吡啶甲酸的生物学制备方法 | |
CN103074320A (zh) | 含有一个或几个点突变的青霉素g酰化酶 | |
CN110423787B (zh) | 一种均一性褐藻三糖的制备方法 | |
CN105950595B (zh) | (-)-γ-内酰胺酶、基因、突变体、载体及其制备与应用 | |
US11760988B2 (en) | L-aspartate alpha-decarboxylase mutant and application thereof | |
KR101725454B1 (ko) | 하프니아 알베이 유래의 라이신 디카르복실라아제를 코딩하는 유전자, 이를 포함하는 재조합 벡터, 숙주세포 및 이를 이용한 카다베린의 생산방법 | |
JP5754682B2 (ja) | D−,l−ペプチドの立体選択的合成法 | |
Asano et al. | Occurrence of 3-methylaspartate ammonia-lyase in facultative anaerobes and their application to synthesis of 3-substituted (S)-aspartic acids | |
CN111378611B (zh) | 一种谷氨酸脱羧酶重组菌及其构建方法和应用 | |
CN108060186B (zh) | 一种对硝基苄醇丙二酸单酯的生物制备方法 | |
CN100354422C (zh) | 一种酯水解酶及其基因和重组酶 | |
RU2593172C2 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pER-TA1 GyrA-AcSer, КОДИРУЮЩАЯ СЕРИНОВУЮ АЦЕТИЛТРАНСФЕРАЗУ, СПОСОБНУЮ in vivo АЦЕТИЛИРОВАТЬ N-КОНЦЕВОЙ СЕРИН ДЕЗАЦЕТИЛТИМОЗИНА α1 И ГИБРИДНЫЙ БЕЛОК, СПОСОБНЫЙ К АВТОКАТАЛИТИЧЕСКОМУ РАСЩЕПЛЕНИЮ С ОБРАЗОВАНИЕМ ТИМОЗИНА α1 ЧЕЛОВЕКА, ШТАММ Eschrichia coli C3030/pER-TA1GyrA-AcSer - ПРОДУЦЕНТ УКАЗАННЫХ БЕЛКОВ И СПОСОБ ПОЛУЧЕНИЯ ГЕННО-ИНЖЕНЕРНОГО ТИМОЗИНА α1 ЧЕЛОВЕКА | |
KR100365838B1 (ko) | 브레비바실러스 보스테렌시스 bcs-1 에서 유래한 신규내열성 d-입체특이적 디펩티다아제 및 이를 이용한d-아미노산 함유 펩타이드의 합성 방법 | |
CN114058608B (zh) | 一种生产腐胺的工程菌及方法 | |
CN116179521B (zh) | 一种精氨酸酶突变体、其重组体及其在连续催化中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C53 | Correction of patent for invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Huang He Inventor after: Zhang Qing Inventor after: Wang Jingang Inventor after: Yuan Zhongyi Inventor after: Yang Cheng Inventor after: Jiang Weihong Inventor before: Huang He Inventor before: Zhang Pan Inventor before: Wang Jingang Inventor before: Yuan Zhongyi Inventor before: Yang Cheng Inventor before: Jiang Weihong |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HUANG HE ZHANG PAN WANG JINGANG YUAN ZHONGYI YANG SHENG JIANG WEIHONG TO: HUANG HE ZHANG QING WANG JINGANG YUAN ZHONGYI YANG SHENG JIANG WEIHONG |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170829 Address after: 201202 Shanghai city Pudong New Area Sichuan Road No. 230 Building 9 Patentee after: SHANGHAI XINGWEI BIOTECHNOLOGY CO., LTD. Address before: 200031 No. 320, Yueyang Road, Shanghai, Xuhui District Patentee before: Shanghai Institute of life Sciences, Chinese Academy of Sciences |
|
TR01 | Transfer of patent right |
Effective date of registration: 20170914 Address after: 037300 first pharmaceutical Park, Datong economic and Technological Development Zone, Shanxi Patentee after: Weiqida Pharmaceutical Co., Ltd. of China National Pharmaceutical Industry Corporation Ltd. Address before: 201202 Shanghai city Pudong New Area Sichuan Road No. 230 Building 9 Patentee before: SHANGHAI XINGWEI BIOTECHNOLOGY CO., LTD. |
|
TR01 | Transfer of patent right |